Drug recall · November 4, 2026
Metoclopramide Tablets recall
Why: Manufacturer is recalling batches due to co-mingled tablet.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Metoclopramide Tablets, USP, 5 mg, 100 Tablets per bottle, Rx Only, Manufactured for: Teva Pharmaceuticals, Parsippany, NJ 07054. NDC: 51079-886-20.
- Lots / codes
Lot # 3116509, Expiry: 07/31/2027.
- Company
- Safecor Health, LLC, Rockford, IL
- Distribution
- US Nationwide
- Initiated
- October 6, 2026 · Voluntary: Firm initiated
- Classified
- October 23, 2026
- Reported
- November 4, 2026
- How notified
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Metoclopramide
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.